Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.0029 | 1 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.00028 | 1 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |